logo
  

Medtronic Says Hugo Robotic-assisted Surgery System Receives Health Canada Licence - Quick Facts

Medtronic Canada ULC, a subsidiary of medical technology company Medtronic plc (MDT) announced Tuesday it has received a Health Canada licence for the Hugo robotic-assisted surgery (RAS) system for use in use in urologic and gynecologic laparoscopic surgical procedures, which make up about half of all robotic procedures performed today.

A modular, multi-quadrant platform indicated for urologic surgical procedures and gynecologic laparoscopic surgical procedures, the Hugo RAS system combines wristed instruments, 3D visualization, and a cloud-based surgical video capture option in Touch Surgery Enterprise with dedicated support teams specializing in robotics program optimization, service, and training.

Health Canada licensing comes on the heels of major milestones in the Hugo RAS system global launch, including the receipt of CE Mark approval in Europe and the first urologic and gynecologic cases in Latin America and India, which are included in the Hugo RAS system patient registry.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Deutsche Post DHL Group were gaining around 6 percent in the morning trading in Germany after the package delivery and logistic major reported Friday higher profit and revenues in its second quarter with strong demand. Going ahead, the company confirmed its 2022 EBIT guidance of 8.0 billion euros, plus or minus 5 percent, even in consideration of a possible global economic downturn. Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday net income for the first quarter halved from last year, hurt by a 1 decline in revenues and a decrease in the market prices of its equity investments in publicly-traded companies. Shares of Deutsche Lufthansa AG were gaining around 6 percent in the morning trading after the German flag carrier reported Thursday a profit in its second quarter, compared to last year's loss, benefited by surge in demand. The company also specified its outlook for the year, and now expects adjusted EBIT to be above 500 million euros for the full year of 2022, in line with current market.
Follow RTT